Piper Sandler Keeps Overweight Rating on Intuitive Surgical (ISRG)

Intuitive Surgical, Inc. (NASDAQ:ISRG) is one of the 10 Best Stocks for 5 Years (Long-Term Stock Portfolio). On August 22, Piper Sandler reiterated its Overweight rating on Intuitive Surgical, Inc. (NASDAQ:ISRG) with a price target of $595. This decision came after a management meeting as part of the firm’s West Coast Bus Trip.

Piper Sandler met with Intuitive Surgical, Inc.’s (NASDAQ:ISRG) Executive Vice President and CFO, Jamie Samath, and Vice President and Head of Investor Relations, Dan Connally.

The research firm noted that on August 21, Intuitive Surgical, Inc. (NASDAQ:ISRG) declined 2.2%. This was a bigger drop than the 1.1% fall in the iShares U.S. Medical Devices ETF (IHI). Piper Sandler suggested that the firm found little justification for this bigger decline.

Piper Sandler keeps a positive outlook on Intuitive Surgical, Inc. (NASDAQ:ISRG). The firm believes there is “ample upside to models, particularly on the procedure side of things.” This positions the company well to beat financial expectations in the future.

These factors are also expected to help Intuitive Surgical, Inc. (NASDAQ:ISRG) maintain its “best-in-class financial profile.”

Intuitive Surgical, Inc. (NASDAQ:ISRG) is an American medical device and technology company that develops and manufactures robotic-assisted surgical systems for physicians and hospitals to make surgery less invasive.

While we acknowledge the potential of ISRG as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 11 Best Revenue Growth Stocks to Buy Now and 11 Best Under-the-Radar Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.